Bristol-Myers Squibb to close manufacturing facility in Cruiserath, Co. Ireland

Bristol-Myers Squibb to close manufacturing facility in Cruiserath, Co. Ireland 

March 6, 2014 -- Bristol-Myers Squibb will close its manufacturing facility in Cruiserath, Co. Dublin by the end of 2015, impacting 130 employees.

This decision to close the Cruiserath facility reflects the changing market demand for a number of products manufactured at the site. Bristol-Myers Squibb will continue manufacturing at the facility until the end of 2015.

The company's other manufacturing facility in Swords Co. Dublin will continue operations, but a single operating unit will cease manufacturing by the end of 2015, impacting 30 employees. The closure of this operating unit in Swords is part of ongoing optimization in the company's manufacturing network. Going forward the Swords facility, employing over 320 people, will remain a key supplier of bulk pharmaceuticals.

Susan Hynes, General Manager API Operations Ireland said ''Bristol-Myers Squibb has a long history in Ireland and the company's presence here plays an important role in the BMS global manufacturing network. The company is working with IDA Ireland to explore potential future uses of the Cruiserath facility and will endeavour to minimize job losses in Ireland''.

 

 

Suggested Articles

Pfizer will exit its Perth, Australia sterile injectables manufacturing site by 2024 as part of a global production reorganization effort.

Agios has withdrawn a European application for Tibsovo in AML after the same phase 1 data that earned it an FDA nod failed to impress the EMA.

Sanofi is reportedly considering a sale of some of its anti-inflammation drugs that could snare $234 million as the company pivots toward Dupixent.